The leadership and agenda of the Food and Drug Administration are expected to change in 2025, with potential implications for regulations on raw milk, vaccines, and processed foods and additives. Robert F. Kennedy Jr. is set to assume a key health role, but his proposals require Senate confirmation. Additionally, FDA commissioner nominee Marty Makary also awaits Senate confirmation, raising questions about how they will work together and what priorities they may set. The future of the agency remains uncertain as it faces a critical year of potential shake-ups and changes in leadership.
Source link
How will FDA change under Trump? 3 issues to watch in 2025
